Tokyo, Aug. 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062599) titled 'Effect of supplementation on recovery of muscle fatigue' on Aug. 18.

Study Type: Interventional

Study Design: Basic Design - Cross-over Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Ritsumeikan University Faculty of Sport and Health Science

Condition: Condition - Healthy adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the effects of hop supplementation on muscle damage, inflammatory responses, and the recovery of muscle function following resistance training Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Daily intake of hop supplementation for 2 weeks - Washout - Daily intake of placebo for 2 weeks Interventions/Control_2 - Daily intake of placebo for 2 weeks - Washout - Daily intake of hop supplementation for 2 weeks

Eligibility: Age-lower limit - 18 years-old = Gender - Male and Female Key inclusion criteria - 1.Individuals aged 18 or higher and less than 27 years old. 2.Individuals who are ability to perform resistance training trial. 3.Individuals who have providec prior infomed consent. Key exclusion criteria - 1.Individuals diagnosed with medical conditions for which exercise is absolutely contraindicated. 2.Individuals with metabolic, respiratory, cardiovascular, or coagulation disorders, or those who have been advised by a physician to avoid high-intensity exercise. 3.Individuals with orthopedic conditions affecting the lower extremities that may interfere with resistance exercise. 4.Individuals currently taking medication or habitually consuming dietary supplements. 5.Individuals with allergies to the test food (including soybeans, hops, hop-derived products, or any other ingredients contained in the test food). 6.Individuals with irregular menstrual cycles or those using oral contraceptives. 7.Individuals who are pregnant, may be pregnant, are planning to become pregnant, or are breastfeeding. 8.Individuals for whom study measurements may be difficult to perform (including women with irregular menstrual cycles). Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 08 Month 04 Day Date of IRB - 2026 Year 08 Month 04 Day Anticipated trial start date - 2026 Year 08 Month 14 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071551

Disclaimer: Curated by HT Syndication.